• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Exosome Diagnostic and Therapeutic Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global exosome diagnostic and therapeutic market looks promising with opportunities in the cancer institutes, hospitals, and diagnostic centers. The global exosome diagnostic and therapeutic market is expected to grow with a CAGR of 35%-40% from 2020 to 2025. The major drivers for this market are increasing demand for diagnosis and screening of chronic diseases coupled with high therapeutic potential of exosomes, favorable government policies related to research and development, and increasing research & development activities.

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global exosome diagnostic and therapeutic market report, please download the report brochure.
 
 
 


In this market, instruments is the largest product of exosome diagnostic and therapeutic, whereas cancer institutes is the largest end user. Growth in various segments of the exosome diagnostic and therapeutic market are given below:
 

 



The study includes trends and forecast for the global exosome diagnostic and therapeutic market by product, application, end user, and region as follows:
 
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Instruments
  • Reagents
  • Software

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Diagnostics
  • Therapeutics

By End User [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Cancer Institutes
  • Hospitals
  • Diagnostic Centers
  • Others

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil
 
Some of the exosome diagnostic and therapeutic companies profiled in this report include 101 BIO, AMS Biotechnology, Therapeutic Solutions International, ReNeuron Group, Immune Therapy Holdings, ExoCyte Therapeutics, Cell Guidance Systems, BioRegenerative Sciences, Evomic Science, and Norgen Biotek.
 
Lucintel forecasts that instruments will remain the largest segment over the forecast period due to increasing usage of instruments in diagnostic applications and increasing cases of cancer that require accurate diagnosis.

Within this market, cancer institutes will remain the largest segment by end user over the forecast period due to increasing demand for advanced diagnostics and therapies for cancer. 

North America will remain the largest region over the forecast period due to increasing healthcare expenditure, technological advancements, and increasing cancer patients.




 
Features of the Global Exosome Diagnostic and Therapeutic Market
 
  • Market Size Estimates: Global exosome diagnostic and therapeutic market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global exosome diagnostic and therapeutic market size by various segments, such as product, application, and end user in terms of value.
  • Regional Analysis: Global exosome diagnostic and therapeutic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products, applications, end users, and regions for the global exosome diagnostic and therapeutic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global exosome diagnostic and therapeutic market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.




 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global exosome diagnostic and therapeutic market by product (instruments, reagents, and software), application (diagnostics and therapeutics), end user (cancer institutes, hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global exosome diagnostic and therapeutic market?
Q.5 What are the business risks and threats to the global exosome diagnostic and therapeutic market?
Q.6 What are the emerging trends in the exosome diagnostic and therapeutic market and the reasons behind them?
Q.7 What are some changing demands of customers in the exosome diagnostic and therapeutic market?
Q.8 What are the new developments in the exosome diagnostic and therapeutic market? Which companies are leading these developments?
Q.9 Who are the major players in the exosome diagnostic and therapeutic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the exosome diagnostic and therapeutic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global exosome diagnostic and therapeutic market?

 


Report Scope





Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)
2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Instrument, Reagent and Software), Application (Diagnostics and Therapeutics), and End User (Cancer Institutes, Hospitals, Diagnostic Centers, and Others)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia Pacific (China, India, and Japan), and ROW (Brazil)

Customization 10% Customization without Any Additional Cost

Table of Contents
 
 
 
1. Executive Summary
 
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Exosome Diagnostic and Therapeutic Market Trends and Forecast
3.3: Global Exosome Diagnostic and Therapeutic Market by Product
3.3.1: Instruments
3.3.2: Reagents
3.3.3: Software
3.4:Global Exosome Diagnostic and Therapeutic Market by Application
3.4.1: Diagnostics
3.4.2: Therapeutics
3.5: Global Exosome Diagnostic and Therapeutic Market by End User
3.5.1: Cancer Institutes
3.5.2: Hospitals
3.5.3: Diagnostic Centers
3.5.4: Others

4. Market Trends and Forecast Analysis by Region
4.1: Global Exosome Diagnostic and Therapeutic Market by Region
4.2: North American Exosome Diagnostic and Therapeutic Market
4.2.1: Market by Product: Instruments, Reagents, and Software
4.2.2: Market by Application: Diagnostics and Therapeutics
4.2.3: Market by End User: Cancer Institutes, Hospitals, Diagnostic Centers, and Others
4.2.4: The United States Exosome Diagnostic and Therapeutic Market
4.2.5: The Canadian Exosome Diagnostic and Therapeutic Market
4.2.6: The Mexican Exosome Diagnostic and Therapeutic Market
4.3: European Exosome Diagnostic and therapeutic Market
4.3.1: Market by Product: Instruments, Reagents, and Software
4.3.2: Market by Application: Diagnostics and Therapeutics
4.3.3: Market by End User: Cancer Institutes, Hospitals, Diagnostic Centers, and Others
4.3.4: The Exosome Diagnostic and Therapeutic Market of the United Kingdom
4.3.5: The German Exosome Diagnostic and Therapeutic Market
4.3.6: The French Exosome Diagnostic and Therapeutic Market
4.4: APAC Exosome Diagnostic and Therapeutic Market
4.4.1: Market by Product: Instruments, Reagents, and Software
4.4.2: Market by Application: Diagnostics and Therapeutics
4.4.3: Market by End User: Cancer Institutes, Hospitals, Diagnostic Centers, and Others
4.4.4: The Chinese Exosome Diagnostic and Therapeutic Market
4.4.5: The Indian Exosome Diagnostic and Therapeutic Market
4.4.6: The Japanese Exosome Diagnostic and Therapeutic Market
4.5: ROW Exosome Diagnostic and Therapeutic Market
4.5.1: Market by Product: Instruments, Reagents, and Software
4.5.2: Market by Application: Diagnostics and Therapeutics
4.5.3: Market by End User: Cancer Institutes, Hospitals, Diagnostic Centers, and Others
4.5.4: Brazilian Exosome Diagnostic and Therapeutic Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Exosome Diagnostic and Therapeutic Market by Product
7.1.2: Growth Opportunities for the Global Exosome Diagnostic and Therapeutic Market by Application
7.1.3: Growth Opportunities for the Global Exosome Diagnostic and Therapeutic Market by End User
7.1.4: Growth Opportunities for the Global Exosome Diagnostic and Therapeutic Market by Region
7.2: Emerging Trends in the Global Exosome Diagnostic and Therapeutic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Exosome Diagnostic and Therapeutic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Diagnostic and Therapeutic Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: 101 BIO 
8.2: AMS Biotechnology Limited
8.3: Therapeutic Solutions International, Inc.
8.4: ReNeuron Group plc.
8.5: Immune Therapy Holdings AB
8.6: ExoCyte Therapeutics Pte Ltd
8.7: Cell Guidance Systems LLC
8.8: BioRegenerative Sciences, Inc. 
8.9: Evomic Science LLC 
8.10: Norgen Biotek Corp
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Exosome Diagnostic and Therapeutic Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
 
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
 
Below is a brief summary of the primary interviews that were conducted by job function for this report.

 
 



Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.